About Index Trending news
Lists
Pricing
Akebia Therapeutics

Akebia Therapeutics

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series C)
$41,000,000
Venture capital (Series B)
$4,100,000
Employees

Unknown size

Locations
HQ
The Motley Fool

Why Epizyme Inc, Akebia Therapeutics Inc, and Cempra Inc Got Wacked Today --

Stock markets Health Costs
The Motley Fool

Why Akebia Therapeutics Shares Soared 10% Today --